Abbott Laboratories's (NYSE:ABT) Q2 Sales Top Estimates [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Its non-GAAP profit of $1.26 per share was in line with analysts' consensus estimates. Is now the time to buy Abbott Laboratories? Find out in our full research report Revenue: $11.14 billion vs analyst estimates of $11.05 billion (7.4% year-on-year growth, 0.9% beat) Adjusted EPS: $1.26 vs analyst estimates of $1.26 (in line) Management reiterated its full-year Adjusted EPS guidance of $5.15 at the midpoint Operating Margin: 18.4%, up from 16.1% in the same quarter last year Organic Revenue rose 6.9% year on year, in line with the same quarter last year Market Capitalization: $229.2 billion "Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly expanded our margin profiles, and continued to advance key programs through our new product pipeline," said Robert B. Ford, chairman and chief executive officer, Abbott. With roots dating back to 1888 when founder Dr. Wallace Abbott began producing precise, dosag
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- What Abbott Laboratories (ABT)'s New Pediatric Heart Device Clearances Mean For Shareholders [Yahoo! Finance]Yahoo! Finance
- ??????????? ???????? - ??????????????????2026-2035? [CNET News]CNET News
- Abbott (ABT): Assessing Valuation After New Regulatory Wins for Its Pediatric Heart Device Innovation [Yahoo! Finance]Yahoo! Finance
- Can Abbott Laboratories (ABT) Deliver Resilient Returns in the Long Term? [Yahoo! Finance]Yahoo! Finance
- Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/19/25 - Form 3
- 12/12/25 - Form 4
- 12/12/25 - Form 8-K
- ABT's page on the SEC website